Post-approval studies (Phase 4)UnknownNCT05299593
What this trial is testing
24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.
Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Fondazione G.B. Bietti, IRCCS 43